As a leading contract research organization, Southern Research provides drug discovery and pre-clinical drug development to pharmaceutical and biotechnology on an outsourced basis.

Southern Research has capabilities in all phases of the early-stage drug discovery and development process with comprehensive services and support. These offerings include proteomics and biodefense/emerging pathogens research, which provide clients with high-impact expertise in streamlining their custom drug discovery and development programs.

Some of Southern Research's significant pre-clinical research accomplishments include:

• demonstrated the efficacy of combination chemotherapy in mice, leading the way for the development of therapeutic approaches with improved clinical outcomes in certain cancers
• performed pre-clinical drug development evaluations and analyses on approximately half of the FDA-approved cancer therapeutics currently on the market
• contributed to the development of the first drug delivery technology for the extended release of synthetic agents that promote the treatment of prostate cancer